Eric Green, M.D.

In this engaging conversation, Eric Green, M.D., Ph.D., a physician-scientist and co-founder of Trace Neuroscience, dives into the world of biotech and genetics-driven therapies. He shares groundbreaking insights on ALS and the pivotal UNC-13A protein, revealing how understanding human genomics can lead to innovative treatments. Eric discusses the challenges of designing clinical trials for severe diseases and the importance of contract manufacturers in biotech innovation. Tune in for a fascinating look at how biotechnology is evolving in the wake of COVID-19!